A group of 12 former professional football players have filed a lawsuit against the National Football League with allegations that it failed to protect players from long-term brain injuries despite evidence showing on-field concussions can lead to such injuries, according to a news release from The Offices of Marc S. Albert.
The suit alleges that NFL officials, including the medical committee, concealed from the players the risks associated with concussions and the side effects of medication administered by NFL personnel to treat concussions. The players allege they were administered Toradol, an anti-inflammatory medication, prior to the games to reduce on-field pain, despite studies showing Toradol can mask symptoms of head injury and induce greater cerebral bleeding.
The lawsuit also addresses previous NFL protocol that returned players to the game shortly after sustaining a head injury and alleges that the NFL has misrepresented medical evidence on concussions since the 1990s.
All players involved in the suit say they suffer from brain impairment and experience symptoms such as short-term memory loss, frequent headaches, lack of sleep and depression.
Related Articles on Concussions:
Cleveland Clinic Study: Modern Football Helmets Have Same Concussion Risks as Leatherheads
Dizziness After Concussion Associated With High Protracted Recovery Risk
Senate Hearing on Concussion-Prevention Product Marketing to Call for New Standards
The lawsuit also addresses previous NFL protocol that returned players to the game shortly after sustaining a head injury and alleges that the NFL has misrepresented medical evidence on concussions since the 1990s.
All players involved in the suit say they suffer from brain impairment and experience symptoms such as short-term memory loss, frequent headaches, lack of sleep and depression.
Related Articles on Concussions:
Cleveland Clinic Study: Modern Football Helmets Have Same Concussion Risks as Leatherheads
Dizziness After Concussion Associated With High Protracted Recovery Risk
Senate Hearing on Concussion-Prevention Product Marketing to Call for New Standards